Synergistic cooperation between ABT-263 and MEK1/2 inhibitor: effect on apoptosis and proliferation of acute myeloid leukemia cells

In spite of intensive research to improve treatment of acute myeloid leukemia (AML) more than half of all patients continue to develop a refractory disease. Therefore there is need to improve AML treatment. The overexpression of the BCL-2 family anti-apoptotic members, like BCL-2 or BCL-xL has been...

Descripción completa

Detalles Bibliográficos
Autores principales: Airiau, Kelly, Prouzet-Mauléon, Valérie, Rousseau, Benoit, Pigneux, Arnaud, Jeanneteau, Marie, Giraudon, Manon, Allou, Kaoutar, Dubus, Pierre, Belloc, Francis, Mahon, François-Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808037/
https://www.ncbi.nlm.nih.gov/pubmed/26625317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808037/
https://www.ncbi.nlm.nih.gov/pubmed/26625317

Ejemplares similares